Idexx Laboratories (IDXX) 114.09 $IDXX
St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), STJ: 78.65 (+0.51), IDXX: 114.09 (+0.93)
The Cooper Companies (COO) Beats Q3 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:27AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.30 in the third quarter of 2016, beating the Zacks Consensus Estimate by 2 cents and improving 16.8% on a year-over-year basis.
BABY: 40.64 (+0.93), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93), COO: 185.92 (+0.55)
FEI Shareholders Approve Thermo Fisher Deal (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 4:44PM CDT
Shareholders of FEI recently approved mega $4.2 billion deal to be acquired by Thermo Fisher Scientific.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)
Thermo Fisher Shareholders Approve FEI Deal, Grows in Electron Microscopy (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 2:59PM CDT
Shareholders of Thermo Fisher recently approved its previously announced mega $4.2 billion acquisition of FEI Company.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)
Henry Schein to Buy Marrodent Stake, Expand in Poland
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 8:48AM CDT
Keeping in line with its strategy of growth through rapid expansion internationally, Henry Schein Inc (HSIC) has agreed to acquire 80% ownership of Marrodent.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93), HSIC: 164.29 (+1.31)
Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:42AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)
Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:08AM CDT
IDEXX Laboratories (IDXX) has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
IDXX: 114.09 (+0.93)
Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93)
PetMed Remains Strong on New Order Sales; Reorder Dips
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:44AM CDT
On Aug 29, 2016, we issued an updated research report on PetMed Express (PETS). This nationwide pet pharmacy presently carries a Zacks Rank #2 (Buy).
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), PETS: 20.38 (+0.19), IDXX: 114.09 (+0.93)
Varian Medical Hits 52 week High, Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:56AM CDT
Share price of Varian Medical rallied to a new 52-week high of $96.31 on Aug 29.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), IDXX: 114.09 (+0.93)
SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.95% Gain
Comtex SmarTrend(R) - Mon Aug 29, 3:41PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $110.02 to a high of $112.48. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $111.27 on volume of 162,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 114.09 (+0.93)
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:37AM CDT
The recent FDA recommendation allowing Hologic???s (HOLX) Procleix assay to be one of the two tests to be used in the nationwide screening will boost its test revenue growth.
DGX: 83.04 (+0.68), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
Bioanalytical (BASI) Launches Sampling System, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 1:10PM CDT
Bioanalytical recently introduced the 'Embrace Automation grant program' featuring 'BASi Culex NxT Automated Blood Sampling system and Raturn.'
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), BASI: 1.17 (unch), IDXX: 114.09 (+0.93)
Shares of IDXX Up 52.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 12:52PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 6 months, Idexx Laboratories has returned 52.79% as of today's recent price of $109.66.
IDXX: 114.09 (+0.93)
Can Veeva Systems (VEEV) Pull an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:49AM CDT
Veeva Systems Inc. (VEEV) is set to report second-quarter fiscal 2017 results on Aug 30.
VEEV: 40.74 (+0.51), LCI: 31.79 (-1.58), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93)
Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ABAX: 49.50 (-0.90), IDXX: 114.09 (+0.93)
Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
Patterson Companies (PDCO) Q1 Earnings Meet Estimates
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 2:55PM CDT
Patterson Companies reported first-quarter fiscal 2017 adjusted earnings of 51 cents per share, in line with the Zacks Consensus Estimate.
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), PDCO: 46.89 (+0.86), IDXX: 114.09 (+0.93)
5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 688.37 (-1.32), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)
Inogen One G4 Cleared for Onboard Use, Market Hold Strong
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:17AM CDT
Inogen recently announced that its One G4 received an approval for an exclusive use on commercial flights.
MASI: 59.90 (+0.47), INGN: 58.11 (+0.16), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)
St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), STJ: 78.65 (+0.51), IDXX: 114.09 (+0.93)
The Cooper Companies (COO) Beats Q3 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:27AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.30 in the third quarter of 2016, beating the Zacks Consensus Estimate by 2 cents and improving 16.8% on a year-over-year basis.
BABY: 40.64 (+0.93), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93), COO: 185.92 (+0.55)
FEI Shareholders Approve Thermo Fisher Deal (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 4:44PM CDT
Shareholders of FEI recently approved mega $4.2 billion deal to be acquired by Thermo Fisher Scientific.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)
Thermo Fisher Shareholders Approve FEI Deal, Grows in Electron Microscopy (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 2:59PM CDT
Shareholders of Thermo Fisher recently approved its previously announced mega $4.2 billion acquisition of FEI Company.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)
Henry Schein to Buy Marrodent Stake, Expand in Poland
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 8:48AM CDT
Keeping in line with its strategy of growth through rapid expansion internationally, Henry Schein Inc (HSIC) has agreed to acquire 80% ownership of Marrodent.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93), HSIC: 164.29 (+1.31)
Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:42AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)
Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:08AM CDT
IDEXX Laboratories (IDXX) has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
IDXX: 114.09 (+0.93)
Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93)
PetMed Remains Strong on New Order Sales; Reorder Dips
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:44AM CDT
On Aug 29, 2016, we issued an updated research report on PetMed Express (PETS). This nationwide pet pharmacy presently carries a Zacks Rank #2 (Buy).
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), PETS: 20.38 (+0.19), IDXX: 114.09 (+0.93)
Varian Medical Hits 52 week High, Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:56AM CDT
Share price of Varian Medical rallied to a new 52-week high of $96.31 on Aug 29.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), IDXX: 114.09 (+0.93)
SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.95% Gain
Comtex SmarTrend(R) - Mon Aug 29, 3:41PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $110.02 to a high of $112.48. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $111.27 on volume of 162,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 114.09 (+0.93)
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:37AM CDT
The recent FDA recommendation allowing Hologic???s (HOLX) Procleix assay to be one of the two tests to be used in the nationwide screening will boost its test revenue growth.
DGX: 83.04 (+0.68), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
Bioanalytical (BASI) Launches Sampling System, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 1:10PM CDT
Bioanalytical recently introduced the 'Embrace Automation grant program' featuring 'BASi Culex NxT Automated Blood Sampling system and Raturn.'
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), BASI: 1.17 (unch), IDXX: 114.09 (+0.93)
Shares of IDXX Up 52.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 12:52PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 6 months, Idexx Laboratories has returned 52.79% as of today's recent price of $109.66.
IDXX: 114.09 (+0.93)
Can Veeva Systems (VEEV) Pull an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:49AM CDT
Veeva Systems Inc. (VEEV) is set to report second-quarter fiscal 2017 results on Aug 30.
VEEV: 40.74 (+0.51), LCI: 31.79 (-1.58), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93)
Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ABAX: 49.50 (-0.90), IDXX: 114.09 (+0.93)
Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
Patterson Companies (PDCO) Q1 Earnings Meet Estimates
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 2:55PM CDT
Patterson Companies reported first-quarter fiscal 2017 adjusted earnings of 51 cents per share, in line with the Zacks Consensus Estimate.
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), PDCO: 46.89 (+0.86), IDXX: 114.09 (+0.93)
5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 688.37 (-1.32), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)
Inogen One G4 Cleared for Onboard Use, Market Hold Strong
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:17AM CDT
Inogen recently announced that its One G4 received an approval for an exclusive use on commercial flights.
MASI: 59.90 (+0.47), INGN: 58.11 (+0.16), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)
